InvestorsHub Logo
icon url

HDGabor

10/29/19 8:20 PM

#221750 RE: Hamoa #221748

H-

Good summary. Agree … as:

I would now expect a settlement sooner than later.

We will see what will be Amarin's view regarding "the company's best interest." … Order or Settlement.

Best,
G
icon url

NickHous

10/29/19 9:28 PM

#221765 RE: Hamoa #221748

Very well written and explained Hamoa. Thank You. This IS good news for AMRN.
icon url

jessellivermore

10/29/19 10:37 PM

#221784 RE: Hamoa #221748

Hamoa...

I am a doctor and not a lawyer...I hope for all the longs that you are correct in your assessment..

I am nervous about the fact that even though the generics have whittled themselves down to straw: they have managed to get their toe inside the Amarin door...Drug labeling and physician behavior are not always predictable...How do you police doctors in their offices..The FDA is not designed to scrutinize the behavior of clinicians...The only exception to that rule I have seen in forty years was the injection of liquid silicone.

There is going to be little or no objection to generic Vascepa in the medical community..Drugs like Repatha and other injectables have the effect of making doctors advocates for cheaper prices...And so are the drug plans..It is very unlikely IMO that they are going to police doctors who violate arbitrary issues like how long a patient will need to be on a drug...So even though most Vascepa patients might need to be on the drug until they expire..There are currently no requirements that doctors need to certify the expected length the patient will be on the drug..And if the doctor is questioned he can merely explain in his opinion the patient needed to be on the drug longer than expected.. The insurance companies also are going to favor the cheaper priced drug..So it is going to be very difficult to monitor the conversion of V into generic V....

":>) JL
icon url

Whalatane

10/29/19 11:54 PM

#221796 RE: Hamoa #221748

Hamoa. Just catching up .
Great post , making it easy for us all to understand .
Thx for contributing to this board
Kiwi
icon url

sharinky

10/30/19 6:36 AM

#221813 RE: Hamoa #221748

Thanks for your analysis. It lines up with AMRN website update and should put everyone at ease.
icon url

massulo52

10/30/19 8:14 AM

#221820 RE: Hamoa #221748

Great analysis.
icon url

irc203

10/30/19 8:36 AM

#221829 RE: Hamoa #221748

Agreed. Thank you for the analysis. I find your analysis to be spot on, but I am only a humble 2L.
icon url

Biobillionair

10/30/19 8:48 AM

#221831 RE: Hamoa #221748

H-

The offers to settle, from Amarin,, will only get smaller by the day. I think that was telegraphed in the update this evening to the Amarin website where they stated, "In Amarin's view, the summary judgement process and today's court ruling have strengthened Amarin's position in the litigation by eliminating from the case several potential lines of generic argument. As such, the ruling strengthens Amarin's position should it determine that case settlement is in the company's best interest."

I would now expect a settlement sooner than later.



I agree 100% thanks for all your comments.

BB
icon url

IgnoranceIsBliss

10/30/19 9:17 AM

#221838 RE: Hamoa #221748

Hamoa, this post was so good I gave it a whole PlusOneCoin. A whole one!

That is like buying a box of cereal, and noticing that the entire box is COVERED with those little squares kids take to school to get a dress down day, and the school gets free cheese or computers or something.

It's that awesome!!!
icon url

Bio_pete

10/30/19 10:12 AM

#221851 RE: Hamoa #221748

"The offers to settle, from Amarin,, will only get smaller by the day."

I don't like the idea of AMRN making any settlement offer. If AMRN can expand the label into other areas then wouldn't they be able to extend the patent life?